Product Information on Elliotts B Solution 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML

Dosage - INJECTABLE; INTRATHECAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Calcium Chloride; Dextrose; Magnesium Sulfate; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate
Multiple ingredients are in alphabetical order.

Strength - 0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML
The potency of the active ingredient(s), Calcium Chloride; Dextrose; Magnesium Sulfate; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate. May repeat for multiple part products.

Applicant - QOL MEDCL
The firm name holding legal responsibility for Elliotts B Solution. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020577
The FDA assigned number to Elliotts B Solution. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Elliotts B Solution. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 27, 1996
The date Elliotts B Solution was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Elliotts B Solution. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Elliotts B Solution is in. Format is RX, OTC, DISCN.

Applicant Full Name - Qol Medical Llc
The full name of the firm holding legal responsibility for the new application of Elliotts B Solution.

Elliotts B Solution

NewDrugInformation